New Zealand Diversified Financial Stock News

Ryman Healthcare (NZSE:RYM) has reported its FY 2026 first half with revenue of NZ$413.5 million and a basic EPS loss of NZ$0.04, while trailing 12 month figures show revenue of NZ$855.6 million and a basic EPS loss of NZ$0.17 as the company works through a period of weaker profitability. The company has seen revenue move from NZ$365.2 million in the first half of FY 2025 to NZ$394.0 million in the second half and now NZ$413.5 million in the first half of FY 2026, with EPS swinging from a...

In recent weeks, the global market landscape has been characterized by a strong performance in small-cap and value stocks, outpacing their large-cap counterparts amid rising inflation concerns and geopolitical tensions. As investors navigate these dynamic conditions, identifying promising opportunities within the small-cap sector can be particularly rewarding, especially when considering companies that exhibit robust insider buying activity. In this context, evaluating factors such as...

Goodman Property Trust (NZSE:GNZ) has just reported its FY 2026 first half results, with revenue of NZ$143.7 million and basic EPS of NZ$0.040161, while the trailing twelve months show revenue of NZ$286.8 million and EPS of NZ$0.081817. Over recent periods, the trust has seen revenue range from NZ$134.8 million to NZ$143.7 million per half year, alongside EPS moving between NZ$0.029568 and NZ$0.041655. This gives investors a clearer view of how income and distributions are tracking. With net...

New Zealand King Salmon Investments Limited ( NZSE:NZK ), might not be a large cap stock, but it led the NZSE gainers...

Fisher & Paykel Healthcare (NZSE:FPH) has opened FY 2026 with first half revenue of NZ$1.1b and basic EPS of NZ$0.36, setting the tone for investors focused on how its profit engine is tracking. The company has seen revenue move from NZ$951.2m and EPS of NZ$0.26 in the first half of FY 2025 to NZ$1.1b and EPS of NZ$0.36 in the latest half, with trailing 12 month EPS reaching NZ$0.80 alongside a net profit margin of 20.2% versus 9.4% a year earlier. This puts profitability firmly in focus as...

Infratil (NZSE:IFT) has opened FY 2026 with first half revenue of NZ$1.99b and basic EPS of NZ$0.33, putting fresh earnings figures in front of investors at a current share price of NZ$15.17. The company has seen revenue move from NZ$1.48b in the first half of FY 2025 to NZ$1.99b in the first half of FY 2026, while basic EPS has shifted from a loss of NZ$0.29 to a profit of NZ$0.33. This frames a clear swing in per share results. Overall, the latest numbers point to firmer margins, with...

EROAD (NZSE:ERD) has just posted its FY 2026 first half numbers, with revenue of NZ$99.1 million and a reported loss of NZ$144.2 million, which translated into EPS of NZ$0.77 loss per share. Over recent periods, revenue has moved from NZ$95.9 million in FY 2025 first half to NZ$98.5 million in FY 2025 second half and NZ$99.1 million in FY 2026 first half, while EPS has ranged from a loss of NZ$0.01 per share in FY 2025 first half to a profit of NZ$0.02 per share in FY 2025 second half before...

Pacific Edge (NZSE:PEB) has opened FY 2026 with first half revenue of NZ$6.8 million and a basic EPS loss of NZ$0.022, while trailing twelve month revenue sits at NZ$13.6 million against a trailing loss of NZ$35.8 million. Over recent half year periods, the company has reported revenue of NZ$11.3 million and NZ$11.4 million in FY 2025 halves with basic EPS losses of NZ$0.018 and NZ$0.018872. This gives investors a view of a business still working to narrow substantial losses at a current...

Auckland International Airport (NZSE:AIA) has released fresh operating data for April 2026, with updated passenger and aircraft movement figures across its Auckland and Queenstown operations that give investors a current read on travel demand. See our latest analysis for Auckland International Airport. The latest traffic figures come as Auckland International Airport's share price sits at NZ$8.27, with a 1-day share price return of 1.85% but a 90-day share price return that has declined...

We note that the Radius Residential Care Limited ( NZSE:RAD ) Independent Director, Bret Jackson, recently sold NZ$164k...

Oceania Healthcare (NZSE:OCA) has reported FY 2026 first half revenue of NZ$131.6 million with basic EPS of NZ$0.0068, setting a measured tone for its latest earnings update. The company has seen half-year revenue move between NZ$132.6 million and NZ$127.9 million over FY 2025, with basic EPS ranging from a loss of NZ$0.0236 to a profit of NZ$0.0656, giving investors a mixed earnings backdrop against which to judge the current report. With trailing 12 month net profit margins sitting near...

AFT Pharmaceuticals (NZSE:AFT) has opened FY 2026 with first half revenue of NZ$114.9 million and basic EPS of NZ$0.03, putting fresh numbers on the table for investors following its growth story. The company has seen revenue move from NZ$86.7 million and basic EPS of a NZ$0.02 loss in the first half of FY 2025 to NZ$121.3 million and basic EPS of NZ$0.14 in the second half of FY 2025, with trailing 12 month EPS most recently sitting at NZ$0.14 on revenue of NZ$254.7 million and net income of...

It's been a pretty great week for AFT Pharmaceuticals Limited ( NZSE:AFT ) shareholders, with its shares surging 11% to...

Turners Automotive Group (NZSE:TRA) opened FY 2026 with first half revenue of NZ$218.3 million and basic EPS of NZ$0.24, setting the tone for how the year is tracking versus the prior twelve months. The company has seen revenue move from NZ$204.4 million in FY 2025 H2 to NZ$218.3 million in FY 2026 H1, while basic EPS shifted from NZ$0.22 to NZ$0.24 over the same reported periods. This gives investors a clear view of performance on the top and bottom line heading into the latest release. With...

Investore Property (NZSE:IPL) has put fresh numbers on the table for FY 2026, with first half revenue of NZ$38.9 million and basic EPS of NZ$0.034 setting the tone for how the year is shaping up. The company has seen recent revenue move from NZ$37.9 million in 2H FY 2025 to NZ$38.9 million in 1H FY 2026, alongside EPS shifting from NZ$0.076 in 2H FY 2025 to NZ$0.034 in the latest half. This gives investors a clear view of how the top line and per share earnings are tracking across periods...

Tower (NZSE:TWR) has put fresh numbers on the table for H1 2026, with total revenue of NZ$309.5 million and basic EPS of NZ$0.09. This helps show how its profitability is holding up through the latest half. The company has seen revenue move from NZ$278.5 million in H1 2024 to NZ$306.9 million in H1 2025 and then to NZ$309.5 million in H2 2025, while basic EPS tracked from NZ$0.09 to NZ$0.15 and then NZ$0.09 over those same half year periods. This gives investors a clearer view of how earnings...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Radius Residential Care Limited ( NZSE:RAD ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is...

Port of Tauranga (NZSE:POT) is back in focus after New Zealand strengthened plant variety rights. This policy shift is aimed at supporting kiwifruit export growth and directly connects to the port’s role handling horticulture volumes. See our latest analysis for Port of Tauranga. At a NZ$8.30 share price, Port of Tauranga’s 30 day share price return of 2.47% and 90 day gain of 5.46% sit alongside a 1 year total shareholder return of 27.49%. Together, these figures point to steadily building...

As global markets grapple with rising inflation and higher energy costs, Asian markets are also experiencing shifts in investor sentiment. Amid these broader economic trends, penny stocks—often smaller or newer companies—remain an intriguing area for investors due to their potential for growth at lower price points. Despite being considered a somewhat outdated term, penny stocks can still offer significant opportunities when backed by strong financials and solid fundamentals.

Ryman Healthcare (NZSE:RYM) has moved into focus after its stock declined ahead of the upcoming 26 May earnings report, with investors watching closely for commentary on profitability pressures and village occupancy trends. See our latest analysis for Ryman Healthcare. Ryman Healthcare's share price has been under pressure, with the 90 day share price return down 17.34% and the year to date share price return down 30.74%, while the 5 year total shareholder return has fallen 80.81%. This...

Argosy Property (NZSE:ARG) has put fresh numbers on the table for FY 2026, with first half revenue at NZ$80.3 million, basic EPS of NZ$0.071, and Funds From Operations of NZ$32.4 million, while trailing 12 month revenue sits at NZ$159.8 million and basic EPS at NZ$0.148. Over recent halves the company has seen revenue move between NZ$78.1 million and NZ$80.3 million, with basic EPS ranging from NZ$0.0389 to NZ$0.109 as FFO per share tracked between NZ$0.0338 and NZ$0.0377. This sets up a...

Napier Port Holdings (NZSE:NPH) has laid out its H1 2026 scorecard with investors focused on how the latest half-year fits into a steadily building earnings profile, including recent trailing 12 month revenue of NZ$164.6 million and basic EPS of NZ$0.144545. Over the last three reported halves, revenue has moved from NZ$70.8 million in H2 2024 to NZ$78.1 million in H1 2025 and NZ$79.7 million in H2 2025, while basic EPS has tracked from NZ$0.047748 to NZ$0.1 and then NZ$0.054318. This sets up...

Serko (NZSE:SKO) has kicked off FY 2026 with first half revenue of NZ$61.1 million and a basic EPS loss of NZ$0.08, alongside a trailing twelve month revenue base of NZ$120.9 million and a TTM EPS loss of NZ$0.14, keeping profitability squarely in focus for investors. The company has seen revenue move from NZ$41.5 million in the first half of FY 2025 to NZ$47.0 million in the second half of FY 2025 and then to NZ$61.1 million in the first half of FY 2026. Losses have shifted from NZ$5.1...